Aktiesnakken — April 2011
-
aktien, det er svært at sige inden vi kender rabatten
-
men mon ikke man skal ud i en solid rabat. Nu skal jeg ikke nævne at genmab og lcp trader tæt på cash?
-
ja netop solsen
-
det gjorde jeg i lcp, men det var så IKKE risikofrit
-
der er nok en del der ikke udnytter sine tegningsretter
-
1,5 mia er lidt dyrt når man skal hente 650 mill
-
det er svært at vurdere før man kender emissions kriterierne, og omvendt reagerede den jo modsat sidst
-
-
Brøndby - lige så snart Bava får pengene i hus på Emission så lufter de en partneraftale
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind